Viologen-based supramolecular compounds with potential herbicidal activity
Novel viologen-derived molecular compounds designed to self-assemble into supramolecular machines via radical-radical interactions. Based on bipyridinium salt chemistry widely used in commercial herbicides, these compounds offer potential applications in crop protection and weed management.
Overview
This research presents novel viologen-based compounds featuring multiple viologen (bipyridinium) units within their molecular structure. These compounds are designed to self-assemble into supramolecular machines through radical-radical interactions. Bipyridinium salts are among the most widely used herbicide classes in agriculture, giving these novel molecular architectures strong potential for herbicidal applications in crop protection and weed management.
Technical specifications
- Molecular design: Compounds incorporate multiple viologen units in their molecular structure, enabling radical-radical self-assembly
- Self-assembly mechanism: Supramolecular machines form through radical-radical interactions between viologen units
- Chemical class: Based on bipyridinium (viologen) salts, a well-established herbicide chemistry
- Structural innovation: Multiple viologen units per molecule differentiate these compounds from conventional single-viologen herbicides
Technology readiness level
This research is at an early discovery stage. The compounds have been designed and synthesized with the hypothesis that their supramolecular self-assembly properties may translate into herbicidal activity. Further validation studies are needed to confirm efficacy, selectivity, and environmental profile before commercial development can be considered.
About Université de Strasbourg
Université de Strasbourg is a large, comprehensive public research university in France's Grand Est region with a strong international outlook. Industry connects through co-located national research-organization units and shared core facilities on campus, alongside integration with the university hospital system for clinical translation. The university leverages nearby research and technology parks and a cross-border innovation corridor at the French–German–Swiss junction, providing streamlined access to suppliers, pilot spaces, and talent pipelines. Research is supported by competitive French and European funding, including the Agence Nationale de la Recherche and the European Commission's Horizon Europe programs. A dedicated technology transfer office works with regional incubators to manage IP, licensing, and startup creation.
delivered to your inbox.